Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler Risom

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Neuro-Oncology Advances|September 9, 2020
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survivalCymon N Kersch, Cheryl J Claunch, Prakash Ambady, et al.
The Journal of Clinical Investigation|November 26, 2019
Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneityTyler Risom, Xiaoyan Wang, Juan Liang, et al.
Cancer Research|November 4, 2018
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal AdenocarcinomaBrittany L Allen-Petersen, Tyler Risom, Zipei Feng, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2012
The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinaseLi Ren, Kateri A Ahrendt, Jonas Grina, et al.
Science Advances|October 22, 2019
MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structureLeeat Keren, Marc Bosse, Steve Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
Discovery and SAR of spirochromane Akt inhibitorsNicholas C Kallan, Keith L Spencer, James F Blake, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2010
Discovery of pyrrolopyrimidine inhibitors of AktJames F Blake, Nicholas C Kallan, Dengming Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationshipsSteve Wenglowsky, Kateri A Ahrendt, Alex J Buckmelter, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKARui Xu, Anna Banka, James F Blake, et al.
Gigascience|August 29, 2025
SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysisXiao Li, Ximo Pechuan-Jorge, Tyler Risom, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Neuro-Oncology Advances|September 9, 2020
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survivalCymon N Kersch, Cheryl J Claunch, Prakash Ambady, et al.
The Journal of Clinical Investigation|November 26, 2019
Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneityTyler Risom, Xiaoyan Wang, Juan Liang, et al.
Cancer Research|November 4, 2018
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal AdenocarcinomaBrittany L Allen-Petersen, Tyler Risom, Zipei Feng, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2012
The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinaseLi Ren, Kateri A Ahrendt, Jonas Grina, et al.
Science Advances|October 22, 2019
MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structureLeeat Keren, Marc Bosse, Steve Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
Discovery and SAR of spirochromane Akt inhibitorsNicholas C Kallan, Keith L Spencer, James F Blake, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2010
Discovery of pyrrolopyrimidine inhibitors of AktJames F Blake, Nicholas C Kallan, Dengming Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationshipsSteve Wenglowsky, Kateri A Ahrendt, Alex J Buckmelter, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKARui Xu, Anna Banka, James F Blake, et al.
Gigascience|August 29, 2025
SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysisXiao Li, Ximo Pechuan-Jorge, Tyler Risom, et al.
Pageof 3